These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

50 related articles for article (PubMed ID: 1816202)

  • 1. Diabetic peripheral neuropathy.
    Das AK; Vijayaraghavan MV
    J Assoc Physicians India; 1991 Oct; 39(10):760-3. PubMed ID: 1816202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis of diabetic neuropathy: role of altered phosphoinositide metabolism.
    Greene DA; Lattimer-Greene S; Sima AA
    Crit Rev Neurobiol; 1989; 5(2):143-219. PubMed ID: 2561904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Disorders of sorbitol and myoinositol metabolism and the activity of sodium, potassium ATPase in the pathogenesis of peripheral neuropathy in patients with diabetes mellitus].
    Mosiewicz J; Grzywa M
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):56-8. PubMed ID: 1329048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contemporary views on the pathogenesis of diabetic neuropathy].
    Pierzchala K
    Wiad Lek; 1998; 51 Suppl 2():30-4. PubMed ID: 9686530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Alterations in the sorbitol pathway and Na(+)-K(+)-ATPase activity of peripheral nerve of alloxan-induced diabetic rats].
    Lu KM; Zhong XL; Zhu XX; Zhu QY
    Sheng Li Xue Bao; 1990 Aug; 42(4):401-5. PubMed ID: 2175949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diabetic neuropathy. Current concepts on etiopathogenesis, diagnosis, and treatment].
    Zorrilla Hernández E; Frati Munari A; Lozano Castañeda O; Villalpando Hernández S; Boulton AJ
    Gac Med Mex; 1994; 130(1):18-25. PubMed ID: 7557046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New concepts and insights on pathogenesis and treatment of diabetic complications: polyol pathway and its inhibition.
    Hotta N
    Nagoya J Med Sci; 1997 Nov; 60(3-4):89-100. PubMed ID: 9481088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pathogenesis of diabetic neuropathies].
    Lalau JD; Arlot S; Quichaud J
    Ann Med Interne (Paris); 1985; 136(6):486-95. PubMed ID: 3909874
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current aspects of research on the pathogenesis of diabetic neuropathy.
    Wuarin-Bierman L; Zahnd GR
    Diabete Metab; 1986 Dec; 12(6):319-24. PubMed ID: 3028879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Correction of diabetic neuropathies using aldose reductase inhibitors and pikamilon].
    Kuchmerovskaia TM; Parkhomets PK; Donchenko GV; Obrosova IG; Klimenko AP; Kuchmerovskiĭ NA; Pakirbaeva LV; Efimov AS
    Vopr Med Khim; 1998; 44(6):559-64. PubMed ID: 10599142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug therapy of diabetic neuropathy.
    Brooks PJ; Francisco GE
    Clin Podiatr Med Surg; 1992 Apr; 9(2):257-74. PubMed ID: 1586903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are disturbances of sorbitol, phosphoinositide, and Na+-K+-ATPase regulation involved in pathogenesis of diabetic neuropathy?
    Greene DA; Lattimer SA; Sima AA
    Diabetes; 1988 Jun; 37(6):688-93. PubMed ID: 2838351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent advances in the pathogenesis of diabetic neuropathy].
    Umehara F
    Nihon Rinsho; 1989 Nov; 47(11):2516-20. PubMed ID: 2601065
    [No Abstract]   [Full Text] [Related]  

  • 14. Human diabetic endoneurial sorbitol, fructose, and myo-inositol related to sural nerve morphometry.
    Dyck PJ; Sherman WR; Hallcher LM; Service FJ; O'Brien PC; Grina LA; Palumbo PJ; Swanson CJ
    Ann Neurol; 1980 Dec; 8(6):590-6. PubMed ID: 7212646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1H-NMR analysis of nerve edema in the streptozotocin-induced diabetic rat.
    Suzuki E; Yasuda K; Yasuda K; Miyazaki S; Takeda N; Inouye H; Omawari N; Miura K
    J Lab Clin Med; 1994 Nov; 124(5):627-37. PubMed ID: 7964120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenesis and prevention of diabetic neuropathy and nephropathy.
    Greene D
    Metabolism; 1988 Feb; 37(2 Suppl 1):25-9. PubMed ID: 2828823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic neuropathy--pathogenesis and precipitating factors].
    Wasada T
    Nihon Rinsho; 1991 Feb; 49 Suppl():159-65. PubMed ID: 1851896
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetic neuropathy--a review of pathological studies].
    Kito S; Yamamura Y
    Nihon Rinsho; 1991 Feb; 49 Suppl():152-8. PubMed ID: 1851895
    [No Abstract]   [Full Text] [Related]  

  • 19. Sorbitol, myo-inositol, and rod outer segment phagocytosis in cultured hRPE cells exposed to glucose. In vitro model of myo-inositol depletion hypothesis of diabetic complications.
    Del Monte MA; Rabbani R; Diaz TC; Lattimer SA; Nakamura J; Brennan MC; Greene DA
    Diabetes; 1991 Oct; 40(10):1335-45. PubMed ID: 1936595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis, classification, and treatment of diabetic peripheral neuropathy.
    Veves A; Sarnow MR
    Clin Podiatr Med Surg; 1995 Jan; 12(1):19-30. PubMed ID: 7720030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.